» Articles » PMID: 37275910

M-MDSC Generation from Mouse Bone Marrow with IL-3 Reveals High Expression and Functional Activity of Arginase 1

Overview
Journal Front Immunol
Date 2023 Jun 5
PMID 37275910
Authors
Affiliations
Soon will be listed here.
Abstract

Myeloid-derived suppressor cells (MDSC) represent major regulators of immune responses, which can control T cells their inducible nitric oxide synthase (iNOS)- and arginase 1 (Arg1)-mediated effector functions. While GM-CSF is well documented to promote MDSC development, little is known about this potential of IL-3, an established growth factor for mast cells. Here, we show that IL-3, similar to GM-CSF, generates monocytic MDSC (M-MDSC) from murine bone marrow (BM) cells after 3 days of culture. At this time point, predominantly CD11b CD49a monocytic and CD11b CD49a FcεR I neutrophilic cells were detectable, while CD11b FcεR I mast cells accumulated only after extended culture periods. Both growth factors were equivalent in generating M-MDSC with respect to phenotype, cell yield and typical surface markers. However, IL-3 generated M-MDSC produced less TNF, IL-1β and IL-10 after activation with LPS + IFN-γ but showed higher Arg1 expression compared to GM-CSF generated M-MDSC. Arg1 was further induced together with iNOS after MDSC activation. Accordingly, an increased Arg1-dependent suppressor activity by the IL-3 generated M-MDSC was observed using respective iNOS and Arg1 inhibitors. Together, these data indicate that M-MDSC can be generated by IL-3, similar to GM-CSF, but with increased Arg1 expression and Arg1-mediated suppression capacity. This protocol now allows further studies on the role of IL-3 for MDSC biology.

Citing Articles

Exploring the Potential of Glycolytic Modulation in Myeloid-Derived Suppressor Cells for Immunotherapy and Disease Management.

Kim J, Choi J, Min H, Hwang K Immune Netw. 2024; 24(3):e26.

PMID: 38974210 PMC: 11224668. DOI: 10.4110/in.2024.24.e26.

References
1.
Broughton S, Hercus T, Hardy M, McClure B, Nero T, Dottore M . Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody. Cell Rep. 2014; 8(2):410-9. DOI: 10.1016/j.celrep.2014.06.038. View

2.
Li Y, Wang Z, Li F, Zhou L, Jiang Y, Yu Y . Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection. Nat Commun. 2022; 13(1):4074. PMC: 9283461. DOI: 10.1038/s41467-022-31723-4. View

3.
Kirshenbaum A, Goff J, Dreskin S, Irani A, Schwartz L, Metcalfe D . IL-3-dependent growth of basophil-like cells and mastlike cells from human bone marrow. J Immunol. 1989; 142(7):2424-9. View

4.
Weber R, Riester Z, Huser L, Sticht C, Siebenmorgen A, Groth C . IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma. J Immunother Cancer. 2020; 8(2). PMC: 7422659. DOI: 10.1136/jitc-2020-000949. View

5.
Veglia F, Sanseviero E, Gabrilovich D . Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021; 21(8):485-498. PMC: 7849958. DOI: 10.1038/s41577-020-00490-y. View